Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis (Q66082860)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis |
clinical trial |
Statements
A Randomized, Double-blind, Placebo-controlled, Phase III Multicenter Study of Subcutaneous Secukinumab in Prefilled Syringes, to Compare Efficacy at 16 Weeks With Placebo and to Assess Safety and Tolerability up to 52 Weeks in Subjects With Active Ankylosing Spondylitis (English)
0 references
18 October 2016
0 references
14 May 2018
0 references
458
0 references
18 year
0 references